A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia

Overview of attention for article published in Orphanet Journal of Rare Diseases, February 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 4 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 23,117 followers.

A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia | Orphanet Journal of Rare Diseases | Full Text https://t.co/LVyrYWkLGE

06 Apr 2022

Reply Repost Favourite

Sugiyama et al: A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia https://t.co/IqVkdmhDiW

05 Mar 2022

Reply Repost Favourite

RT @dazzle4rare: A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia https:…

25 Feb 2022

Reply Repost Favourite

A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia https://t.co/VeAA8ejPzX

25 Feb 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.